DI FENG
Summary
Scientific researcher with expertise in computational and biological disciplines, specializing in drug development and biomedical research. Skilled in designing bioinformatics workflows, conducting large-scale data analysis, and developing tools. Excels in interdisciplinary collaboration and engaging with stakeholders and external experts. Strong coding skills and adept at mentoring postdoctoral fellows. Dedicated Life Scientist with experience in laboratory research, possessing expertise in data analysis, biochemistry, and genetics. Proficient in using advanced laboratory equipment and techniques. Believes in the positive impact of AI on humanity.
Overview
25
25
years of professional experience
1
1
Certification
Work History
Senior Principal Scientist | Computational Innovation
Boehringer Ingelheim Pharmaceuticals
01.2024 - Current
- Collaborated in oncology drug discovery using agentic AI and LLM models for research involving multi-modal genomics data, knowledge databases, and literature
- Applied sophisticated AI applications and guided postdoctoral fellows in the biomedical data science program at Yale University
Senior Principal Scientist | Comp Bio and Digital Sciences
Boehringer Ingelheim Pharmaceuticals
01.2019 - 01.2024
- Led drug target discovery for Cancer Immunology
- Designed regulatory safety pipelines for viral modeling, molecular simulations, and genomic risk analysis
- Functional genomics, Image-based analysis
- Shared findings with stakeholders and collaborators
- Managed AI/ML partnership with CCIPD at Case Western's University Hospital
- Co-Mentored postdoctoral fellows in the biomedical data science program at Yale University
Computational Biology Expert Team Lead
Boehringer Ingelheim Pharmaceuticals
01.2018 - 01.2019
- Managed a team of computational scientists on projects spanning oncology, immunology, fibrosis, and cardio-metabolism research using multi-omics and data-driven insights
- Developed open-source software tools facilitate collaboration between computational biologists and experimental scientists
- Applied AI/ML methodologies to analyze high-dimensional datasets, histopathology and imaging genomics
Principal Scientist | Integrative Biology
Boehringer Ingelheim Pharmaceuticals
01.2013 - 01.2018
- Drug discovery for immuno-inflammation (I&I) disease area
Research Associate
Cancer Institute of New Jersey
01.2006 - 01.2013
- Research on autoimmune and cancer susceptibility genes, integrating bioinformatics with wet lab science
- Used genetic, molecular and cell biology methods to investigate potential therapeutic targets
- Research supported by the Lupus Research Alliance
Predoctoral Fellow | Molecular Immunology & Experimental Pathology
Rutger University
09.2000 - 01.2006
- Conducted NIH (R1)-sponsored AIDS clinical research, studying innate immunity dysfunction in HIV infection
- Participated in bioassay development for an Air Decontamination System 'Anti-Terrorism - Survivability and Denial' for Plasmasol Corporation
Education
Ph.D. - Molecular Immunology & Experimental Pathology
Rutgers University
Newark, NJ01.2006
Skills
- Python
- R
- PyTorch
- LLM
- LangChain
- LangGraph
- Machine learning
- Biostatistics
- AWS, Databricks, HPC
- Hypothesis generation
- Knowledge discovery
- Experiential design
- Biostatistics
- Bioinformatics
- Software development
- Rodent models
- Assay development
- DNA/RNA Molecular clone
- Cell isolation, Flow, IHC, ELISA
- Safety processes and procedures
- Regulatory compliance
Websites
Key Expertise
Utilized Large Language Models (LLMs), Retrieval Augmented Generation (RAG), Agentic workflows, and knowledge construction techniques. Implemented Lab in a Loop for drug discovery, biomarker discovery, and disease cell and molecular biology., Investigated biological agents such as viruses, bacteria, toxins, infectious diseases, host responses, sequence design, protein modeling, generative protein models, molecular virology, immunology, and risk assessment., Conducted benchmarking, threat assessments, and designed evaluation pipelines., Engaged with research groups, government stakeholders, and cross-functional partners.
Certification
Certified Medical School Graduate by Educational Commission for Foreign Medical Graduates (2010)
Languages
English
Timeline
Senior Principal Scientist | Computational Innovation
Boehringer Ingelheim Pharmaceuticals
01.2024 - Current
Senior Principal Scientist | Comp Bio and Digital Sciences
Boehringer Ingelheim Pharmaceuticals
01.2019 - 01.2024
Computational Biology Expert Team Lead
Boehringer Ingelheim Pharmaceuticals
01.2018 - 01.2019
Principal Scientist | Integrative Biology
Boehringer Ingelheim Pharmaceuticals
01.2013 - 01.2018
Research Associate
Cancer Institute of New Jersey
01.2006 - 01.2013
Predoctoral Fellow | Molecular Immunology & Experimental Pathology
Rutger University
09.2000 - 01.2006
Ph.D. - Molecular Immunology & Experimental Pathology
Rutgers University
Similar Profiles
RIHAN EL BEZAWYRIHAN EL BEZAWY
Medical Affairs Lead – Dermatology & Oncology at Boehringer Ingelheim PharmaceuticalsMedical Affairs Lead – Dermatology & Oncology at Boehringer Ingelheim Pharmaceuticals
Leslie Shawn HollisLeslie Shawn Hollis
Sterile Processing Technician at Boehringer Ingelheim PharmaceuticalsSterile Processing Technician at Boehringer Ingelheim Pharmaceuticals
Elizabeth Russell-KellyElizabeth Russell-Kelly
Associate Director, Content Enablement at Boehringer Ingelheim PharmaceuticalsAssociate Director, Content Enablement at Boehringer Ingelheim Pharmaceuticals
William E BrittWilliam E Britt
Executive Diabetes Business Specialist at Boehringer Ingelheim PharmaceuticalsExecutive Diabetes Business Specialist at Boehringer Ingelheim Pharmaceuticals
Dr. Bakht AliDr. Bakht Ali
Senior Innovation Principal Scientist at CGUSASenior Innovation Principal Scientist at CGUSA